CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas

Clinical trial NCT06925464 · RECRUITING

Trial details

NCT number: NCT06925464
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-Cell Non-Hodgkin Lymphoma T-cell Lymphoma (PTCL and CTCL)

Start date: 2025-04-01
Primary completion: 2026-04-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.